- Ownership hops held
- 20
An absent edge means not yet observed — never does not exist.
Gain Therapeutics, Inc.
Gain Therapeutics, Inc. — US company (sec:0001819411). UBO chain traced 20 hops. Every claim linked to its source.
Ownership resolves 20 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
No ownership or control links resolved yet
An absent link means “not yet observed in our current sources”, not that none exists — cross-source resolution is still growing.
We flag the moment ownership, a filing or a sanctions signal lands on it — the fastest way to catch a change on a subject we hold little on today.
20-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on Gain Therapeutics, Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBOSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
10 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- ALDER MATTHIASAlso holds roles at 2 other companies
- SUCAMPO PHARMACEUTICALS, INC.officer
- CANCERVAX CORPofficer
- BALLANTYNE CHARLES EVANAlso holds roles at 3 other companies
- AGENUS INCofficer
- ADEONA PHARMACEUTICALS, INC.officer
- CLINICAL DATA INCofficer
- GOLDSTEIN DOV A MDAlso holds roles at 12 other companies
- Coya Therapeutics, Inc.director
- BioAge Labs, Inc.officer
- BBM HOLDINGS, INC.director
- HASLER HANS PETERAlso holds roles at 3 other companies
- MINERVA NEUROSCIENCES, INC.director
- PATHEON HOLDINGS COOPERATIEF U.A.director
- BIOGEN INC.officer
- ISLAM KHALIDAlso holds roles at 3 other companies
- FENNEC PHARMACEUTICALS INC.director
- Processa Pharmaceuticals, Inc.director
- IMMUNOMEDICS INCdirector
- MELINCOFF GWEN AAlso holds roles at 5 other companies
- ANCHIANO THERAPEUTICS LTD.director
- EMBASSY ACQUISITION CORPdirector
- COLLEGIUM PHARMACEUTICAL, INCdirector
- Nicaise ClaudeAlso holds roles at 3 other companies
- Sarepta Therapeutics, Inc.director
- ANCHIANO THERAPEUTICS LTD.director
- CASSAVA SCIENCES INCdirector
- RICHMAN ERIC IAlso holds roles at 5 other companies
- BBM HOLDINGS, INC.director
- ADMA BIOLOGICS, INC.director
- Altimmune, Inc.director
- RILEY JEFFREY SCOTTAlso holds roles at 2 other companies
- ADEONA PHARMACEUTICALS, INC.officer
- ADEONA PHARMACEUTICALS, INC.director
10 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Gain Therapeutics, Inc.?
- What is Gain Therapeutics, Inc.'s risk level?
- Where does Gain Therapeutics, Inc. appear across sources?